Our Science

Publications & Articles

Publications.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

ABCL575

SID Annual Meeting 2025

Preclinical development of ABCL575, a half-life extended anti-OX40L monoclonal antibody for the treatment of autoimmune conditions

T-Cell Engagers

AACR Annual Meeting 2025

PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer

T-Cell Engagers

SITC Annual Meeting 2024

Profiling bispecific T-cell engagers: Strategies for enhancing potency while minimizing cytokine release

T-Cell Engagers

AACR Annual Meeting 2024

Development of PSMA x CD3 T-cell engagers using an integrated, functional approach

T-Cell Engagers

AACR Annual Meeting 2024

Targeting intracellular tumor antigens to fight cancer: discovery and development of functional and specific T-cell engagers against a MAGE-A4 pMHC

Journal articles.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

ACS Omega

July 27, 2021

Screening Antibodies Raised against the Spike Glycoprotein of SARS–CoV–2 to Support the Development of Rapid Antigen Assays

Read article

Science Translational Medicine

May 12, 2021

The neutralizing antibody, LY-CoV555, protects against SARS–CoV–2 infection in nonhuman primates

Read article

mAbs

December 31, 2020

Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants

Read article

Stem Cell Reports

January 10, 2017

Dissociation of survival, proliferation, and state control in human hematopoietic stem cells

Read article

Publications.

Preclinical development of ABCL575, a half-life extended anti-OX40L monoclonal antibody for the treatment of autoimmune conditions

PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer

Profiling bispecific T-cell engagers: Strategies for enhancing potency while minimizing cytokine release

Development of PSMA x CD3 T-cell engagers using an integrated, functional approach

Diverse CD28-binding antibodies for costimulatory T-cell engager development

Functional and specific T-cell engagers for a peptide-MHC tumor target

Target-dependent considerations for the design of bispecific T-cell engagers

Discovery of diverse GPCR-targeted antibodies using integrated technologies

Targeting intracellular tumor antigens to fight cancer: discovery and development of functional and specific T-cell engagers against a MAGE-A4 pMHC

Journal articles.

Screening Antibodies Raised against the Spike Glycoprotein of SARS–CoV–2 to Support the Development of Rapid Antigen Assays

The neutralizing antibody, LY-CoV555, protects against SARS–CoV–2 infection in nonhuman primates

Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants

Dissociation of survival, proliferation, and state control in human hematopoietic stem cells